Why IMU is a multi multi bagger, page-23734

There is one undeniable fact about IMU, and that is it is truly a company share that has for some time been transferred from the impatient to the patient, or in other words retail investors to the big manipulators of the market.
We have Acer-cel, OnCARlytics, Vaxinia with hNis, Hervacc and PD1 Vacc, 5 shots at goal, all these at Ph1 and Ph2 trials, and yet we continue to languish below 10c.
We also have over $130M in the bank with the government investment payment.
In comparison another Biotech that I will not name has one shot on goal, not even in a Ph1 trial and yet they sit on 11.5c, how can this be rationalised without coming to the conclusion the market is manipulated.
I actually hope that this is the case as all I would need to do is hold until the games are over.
@DTshares suggested it is due to the many failures of the company, what failures, all the trials have been ongoing with not one setback.
The same people are at the top, Human Fong was again present at a recent investor seminar according to Leslie, we are still moving along at a rapid pace.

DYOR opinion only